- AuthorisedTherapeutic exploratory (Phase II)
Phase II study of Cemiplimab before and after standard chemoradiotherapy for patients with locally advanced cervical carcinoma. CADILLACC TRIAL
This study is testing a new way to treat locally advanced cervical cancer. It combines standard chemotherapy and radiation with a new drug called Libtayo before and after those treatments, to see if it helps reduce the cancer.
For: locally advanced cervical carcinomaItaly - AuthorisedTherapeutic confirmatory (Phase III)
Toripalimab plus chemotherapy as first-line treatment for recurrent and/or metastatic nasopharyngeal cancer: safety and activity in non-endemic population
This study is testing a new combination of treatments, including a drug called toripalimab, for a type of cancer called nasopharyngeal cancer that has come back or spread. Doctors want to see if this new treatment is safe and works well for people outside of areas where the cancer is common.
For: Recurrent Metastatic Nasopharingeal CarcinomaItaly